We are live on ! Find out more
Vanguard Capital Management

Vanguard Capital Management Portfolio holdings

AUM $4.68T
This Fund
S&P 500
This Quarter Est. Return
+26.64%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.68T
AUM Growth
+$637B
Cap. Flow
+$33.9B
Cap. Flow %
0.72%
Top 10 Hldgs %
32.56%
Holding
4,163
New
101
Increased
2,575
Reduced
1,196
Closed
71

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$4.59B
2
CTRA
Coterra Energy
CTRA
+$1.69B
3
CRM icon
Salesforce
CRM
+$1.28B
4
JPM icon
JPMorgan Chase
JPM
+$1.15B
5
HOLX
Hologic
HOLX
+$1.1B

Sector Composition

Rank Sector Weight
1 Technology 36.14%
2 Financials 12.19%
3 Industrials 9.6%
4 Healthcare 9.39%
5 Consumer Discretionary 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCTV
3301
Octave Intelligence
OCTV
$5B
$2.88M ﹤0.01%
+176,811
New +$3.25M
APT icon
3302
Alpha Pro Tech
APT
$54.9M
$2.88M ﹤0.01%
512,476
-41,198
-7% -$215K
FGBI icon
3303
First Guaranty Bancshares
FGBI
$150M
$2.86M ﹤0.01%
283,913
+18,203
+7% +$175K
PNRG icon
3304
PrimeEnergy Resources
PNRG
$344M
$2.86M ﹤0.01%
17,108
+3,034
+22% +$642K
XGN icon
3305
Exagen
XGN
$160M
$2.85M ﹤0.01%
612,832
-65,820
-10% -$248K
ATRA icon
3306
Atara Biotherapeutics
ATRA
$87.5M
$2.84M ﹤0.01%
247,047
+29,185
+13% +$233K
STEM icon
3307
Stem
STEM
$56.2M
$2.82M ﹤0.01%
361,249
+17,436
+5% +$162K
CSPI icon
3308
CSP Inc
CSPI
$73.4M
$2.81M ﹤0.01%
354,154
-276
-0.1% -$2.52K
LIDR icon
3309
AEye
LIDR
$58.1M
$2.79M ﹤0.01%
1,940,884
-571,300
-23% -$1.03M
PLRX icon
3310
Pliant Therapeutics
PLRX
$71.2M
$2.78M ﹤0.01%
2,440,351
+97,250
+4% +$118K
SUIG
3311
Sui Group Holdings
SUIG
$65.5M
$2.78M ﹤0.01%
2,395,042
-548,625
-19% -$790K
NSTS icon
3312
NSTS Bancorp
NSTS
$68.4M
$2.78M ﹤0.01%
201,759
+11,816
+6% +$155K
BGSF icon
3313
BGSF Inc
BGSF
$59.2M
$2.77M ﹤0.01%
484,995
-5,325
-1% -$29.6K
RLYB icon
3314
Rallybio
RLYB
$89.1M
$2.76M ﹤0.01%
172,497
+60,457
+54% +$778K
ORBS
3315
Eightco Holdings
ORBS
$257M
$2.75M ﹤0.01%
3,945,078
+2,081,416
+112% +$1.87M
PTHS
3316
Pelthos Therapeutics
PTHS
$100M
$2.75M ﹤0.01%
97,134
+4,041
+4% +$104K
CMTL icon
3317
Comtech Telecommunications
CMTL
$52.4M
$2.74M ﹤0.01%
1,306,904
+112,576
+9% +$433K
PMVP icon
3318
PMV Pharmaceuticals
PMVP
$66.1M
$2.7M ﹤0.01%
2,012,020
+37,114
+2% +$47.6K
ICCC icon
3319
ImmuCell
ICCC
$88.6M
$2.69M ﹤0.01%
268,130
+7,803
+3% +$68.9K
DTCX
3320
Datacentrex Inc
DTCX
$79.5M
$2.69M ﹤0.01%
1,510,640
-121,503
-7% -$268K
CITR
3321
CitroTech Inc
CITR
$2.69M ﹤0.01%
486,620
+62,452
+15% +$442K
LFVN icon
3322
LifeVantage
LFVN
$80.4M
$2.68M ﹤0.01%
429,203
-219
-0.1% -$1.33K
RSSS icon
3323
Research Solutions
RSSS
$74.6M
$2.66M ﹤0.01%
1,147,020
+13,549
+1% +$32.2K
NFE icon
3324
New Fortress Energy
NFE
$84M
$2.63M ﹤0.01%
7,257,110
+74,608
+1% +$44.4K
WBTN
3325
WEBTOON Entertainment Inc
WBTN
$1.12B
$2.6M ﹤0.01%
228,068
+20,079
+10% +$238K

Similar funds

Vanguard Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 4.1%. Vanguard Capital Management opened 101 new positions and exited 71, leaving the 4,163-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.

  • Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
  • Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
  • Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
  • Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
  • Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
  • Vanguard Capital Management opened 101 new positions and closed 71 in Q2 2026.
  • Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.